Why have Pro Medicus shares hit a record high on Monday?

This popular tech stock is scaling new heights on Monday.

| More on:
A group of people in a corporate setting do a collective high five.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares have started the week positively.

In fact, the health imaging technology company's shares have climbed to a record high of $88.69.

Why are Pro Medicus shares rising?

The catalyst for this rise has been the release of the company's annual general meeting update this morning.

Ahead of the event, Pro Medicus released a presentation that spoke positively about both its performance in the first quarter and its outlook.

In respect to the first quarter, the company revealed that it is "ahead of budget on constant currency."

It also highlights that, as we have covered previously, it has achieved a "record level of contract wins in the first 5 months" of the financial year. A total of $200 million will be generated from these contracts at a minimum.

Management also notes that these "contract wins span multiple market segments" which reinforces its large total addressable market.

Pleasingly, despite its record contract wins, it still has a strong pipeline across a broad range of opportunities. Furthermore, it is strategically positioned to leverage artificial intelligence and other ologies.

Commenting on FY 2024, Pro Medicus' chair, Peter Kempen, said:

The budget for the current financial year has been determined recognising anticipated continuing strong growth, from both existing and new clients. I am pleased to advise that results to date are ahead of budget on a constant currency basis and further ahead with the impact of a lower Australian dollar, relative to the US dollar. We anticipate that the second half of the financial year will be stronger than the first half, as is traditionally the case.

Looking further ahead, Kempen is very positive on the company's medium-term outlook. He adds:

As I mentioned at last year's AGM the Company has adopted a new strategic plan for FY24-FY26 which sets our objectives and our strategies for the next three years. The Board and management have set aggressive growth targets in keeping with the Company's current and potential opportunities. We are in the process of progressively implementing our plans to achieve our next growth phase. We are all committed to achieving further successful outcomes envisaged within the new strategic plan.

Pro Medicus shares are up over 50% on a 12-month basis.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Technology Shares

Here are 2 exciting ASX shares rated as buys

These shares are highly rated by brokers. Let's find out why.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

Is this the decade of the data centre? One ASX 200 stock that could benefit

Let's see why one leading broker thinks this stock could be destined for big things.

Read more »

A human-like robot checks out market performance on a laptop, indicating the rise of AI shares.
Technology Shares

3 top performing ASX AI shares for your watchlist

Have you positioned your portfolio to capitalise on the next tech revolution?

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
AI Stocks

3 reasons to buy NextDC shares today

A leading expert forecasts more growth to come for NextDC's rebounding shares.

Read more »

A share market analyst looks at his computer screen in front of him showing ASX share price movements
Technology Shares

Why this $3.9 billion acquisition makes Xero shares a buy today

A leading expert forecasts that Xero’s $3.9 billion investment is about to pay off.

Read more »

Three young people in business attire sit around a desk and discuss.
Small Cap Shares

Tiny tech: 3 ASX small-cap shares with new ratings

Toby Grimm of Baker Young and Peter Day of Sequoia Wealth Management share their new ratings.

Read more »

Smiling young parents with their daughter dream of success.
Technology Shares

Could Life360 shares rise to $37.50?

Bell Potter has given its verdict on this tech stock.

Read more »

Man smiling at a laptop because of a rising share price.
Technology Shares

Investors should put these 2 top ASX tech shares on the watchlist

Looking for growth? These two stocks are delivering.

Read more »